Safi R. Bahcall

2008

In 2008, Safi R. Bahcall earned a total compensation of $1M as President and Chief Executive Officer at Synta Pharmaceuticals, a 16% increase compared to previous year.

Compensation breakdown

Option Awards$578,100
Salary$380,000
Other$71,415
Total$1,029,515

Bahcall received $578.1K in option awards, accounting for 56% of the total pay in 2008.

Bahcall also received $380K in salary and $71.4K in other compensation.

Rankings

In 2008, Safi R. Bahcall's compensation ranked 4,309th out of 9,135 executives tracked by ExecPay. In other words, Bahcall earned more than 52.8% of executives.

ClassificationRankingPercentile
All
4,309
out of 9,135
53rd
Division
Manufacturing
1,545
out of 3,436
55th
Major group
Chemicals And Allied Products
296
out of 815
64th
Industry group
Drugs
176
out of 597
71st
Industry
Pharmaceutical Preparations
127
out of 408
69th
Source: SEC filing on April 29, 2011.

Bahcall's colleagues

We found four more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2008.

2008

James Barsoum

Synta Pharmaceuticals

Senior Vice President, Research

2008

Eric Jacobson

Synta Pharmaceuticals

Chief Medical Officer

2008

Keizo Koya

Synta Pharmaceuticals

Senior Vice President, Drug Development

2008

Keith Ehrlich

Synta Pharmaceuticals

Chief Financial Officer

In-depth

You may also like